CAMK2A and major depressive disorder: Similarly, in the mouse model of depression induced by lipopolysaccharide, the extrasynaptic increase in CaMKIIα expression was attenuated by ketamine administration and treatment with CaMKIIα inhibitor KN-93 [136].